Table 1.
Clinicopathological characteristics.
| Characteristics | Number of patients (%) | ZNF304 expression | ||
|---|---|---|---|---|
| Low (%) | High (%) | P value | ||
| No. of patients | 45 | 22 | 23 | |
| Age | ||||
| ≤60 | 22 | 11 (50.00) | 11 (50.00) | 1.000 |
| >60 | 23 | 11 (47.83) | 12 (52.17) | |
| Gender | ||||
| Male | 30 | 16 (53.33) | 14 (46.67) | 0.530 |
| Female | 15 | 6 (40.00) | 9 (60.00) | |
| Tumor size (cm) | ||||
| ≤5 | 27 | 12 (44.44) | 15 (55.56) | 0.550 |
| >5 | 18 | 10 (55.56) | 8 (44.44) | |
| pT status | ||||
| pT1–pT2 | 18 | 11 (61.11) | 7 (38.89) | 0.125 |
| pT3–pT4 | 27 | 9 (33.33) | 18 (66.67) | |
| pN status | ||||
| pN0 | 30 | 14 (46.67) | 16 (53.33) | 0.758 |
| pN1–pN3 | 15 | 8 (53.33) | 7 (46.67) | |
| TNM stage | ||||
| I–II | 28 | 10 (35.71) | 18 (64.29) | 0.033 |
| III–IV | 17 | 12 (70.59) | 5 (29.41) | |